%0 Journal Article
%A Kayser, Sabine
%A Benner, A.
%A Thiede, C.
%A Martens, U.
%A Huber, J.
%A Stadtherr, P.
%A Janssen, J. W. G.
%A Röllig, C.
%A Uppenkamp, M. J.
%A Bochtler, T.
%A Hegenbart, U.
%A Ehninger, G.
%A Ho, A. D.
%A Dreger, P.
%A Krämer, Alwin
%T Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.
%J Blood cancer journal
%V 6
%N 7
%@ 2044-5385
%C London [u.a.]
%I Nature Publishing Group
%M DKFZ-2017-04890
%P e449 -
%D 2016
%X The objective was to evaluate the prognostic impact of pre-transplant minimal residual disease (MRD) as determined by real-time quantitative polymerase chain reaction in 67 adult NPM1-mutated acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). Twenty-eight of the 67 patients had a FLT3-ITD (42
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:27471865
%2 pmc:PMC5030374
%R 10.1038/bcj.2016.46
%U https://inrepo02.dkfz.de/record/128877